Tokyo, June 27 (IANS/EFE) A team of Japanese scientists has discovered a method that extends the life of mice with amyotrophic lateral sclerosis (ALS), a neurodegenerative disease for which there is no effective cure, media reported Friday.
The scientists managed to successfully transplant progenitor cells derived from induced pluripotent stem cell (IPS) of humans to the spinal medulla of mice, which may mean that the treatment is effective in people, Kyodo news agency reported.
The method helped extend the life of the rodents with symptoms of the illness by 10 days, which is equivalent to six months of life in humans, according to the scientists, who published their finding in the American scientific newspaper Stem Cell Reports.
The doctors transplanted around 80,000 cells of this type in 24 mice suffering from ALS, which helped the rodents to live 162 days in comparison with 150 days of the mice who did not receive transplants.
However, the team of doctors from Tokyo University pointed out the difficulty of applying the same method to people.
Currently there is no effective treatment of ALS, also known as motor neuron disease (MND) in pathology and Charcot disease.
Symptoms of ALS are muscle weakness and atrophy of the entire body caused due to degeneration of upper and lower motor neurons.
Cell transplant is considered as a promising method for ALS, although the difficulties of having a steady supply of cells and the possibilities of rejection by the recipient organism are delaying the progress on this field, according to the Japanese scientists.
The usage of induced pulripotent cells could solve these problems, the team of scientists, led by professor Haruhisa Inoue, added in their article.
--IANS/EFE
ab/vt
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
